Armistice Capital »

Charles River Laboratories shares owned by Armistice Capital

Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Charles River Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Charles River Laboratories held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Charles River Laboratories by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $31M 156k 195.98

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Charles River Laboratories

Vanguard Group
ClearBridge Advisors
T. Rowe Price Associates
Meritage Group
Allspring Global Investments Holdings
Southpoint Capital Advisors
Mackenzie Financial
Earnest Partners
Franklin Resources
Bank of America Corporation
Wells Fargo & Company
Charles Schwab Investment Management
Montrusco Bolton Investment
Dimensional Fund Advisors
Victory Capital Management

View all funds holding Charles River Laboratories